4571 On Other Exchanges
Symbol
Exchange
4571 is not on other exchanges.

nanocarrier co ltd (4571) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANOCARRIER CO LTD (4571)

Related News

No related news articles were found.

nanocarrier co ltd (4571) Related Businessweek News

No Related Businessweek News Found

nanocarrier co ltd (4571) Details

NanoCarrier Co., Ltd. researches and develops, and produces pharmaceuticals primarily for the treatment of cancer in Japan. Its product pipeline includes Nanoplatin for the treatment of pancreatic, head and neck, non-small cell lung, bladder, and bile duct cancers; Oxaliplatin to treat bowel cancer; Epirubicin Micelle for solid cancer; and Paclitaxel, an anticancer drug for the treatment of ovarian, non-small cell lung, breast, stomach cancers, etc. The company is also developing antibody/drug conjugated micelle and Active-NanoFect. NanoCarrier Co., Ltd. was founded in 1996 and is headquartered in Kashiwa, Japan.

55 Employees
Last Reported Date: 06/27/16
Founded in 1996

nanocarrier co ltd (4571) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanocarrier co ltd
NanoCarrier Co., Ltd. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 10:30 AM

NanoCarrier Co., Ltd. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 10:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Ichiro Nakatomi, Chief Executive Officer, President and Representative Director.

NanoCarrier Co., Ltd. Reports Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2017

NanoCarrier Co., Ltd. reported non-consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported net sales of JPY 83.882 million against JPY 13.085 million a year ago. Operating loss was JPY 1,276.050 million against JPY 921.735 million a year ago. Ordinary loss was JPY 1,770.096 million against JPY 904.626 million a year ago. Loss before income taxes was JPY 1,770.143 million against JPY 904.649 million a year ago. Net loss was JPY 1,771.958 million against JPY 906.606 million a year ago. Net cash used in operating activities was JPY 1,277.311 million against JPY 766.242 million a year ago. Purchase of property, plant and equipment was JPY 48.734 million against JPY 49.227 million a year ago. For the year ending March 31, 2017, the company expects net sales of JPY 182 million, operating loss of JPY 3,452 million, ordinary loss of JPY 3,410 million and net loss of JPY 3,475 million or JPY 80.60 per share.

NanoCarrier Co., Ltd. to Report Q2, 2017 Results on Nov 11, 2016

NanoCarrier Co., Ltd. announced that they will report Q2, 2017 results on Nov 11, 2016

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4571 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4571.
View Industry Companies
 

Industry Analysis

4571

Industry Average

Valuation 4571 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 109.4x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 61.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NANOCARRIER CO LTD, please visit www.nanocarrier.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.